Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00507156
Status:
COMPLETED
Last Update Posted:
2016-10-06
First Post:
2007-07-23
Brief Title:
Postconditioning in the Treatment of Acute ST-segment Elevation Myocardial Infarction
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Study Overview
Official Title:
Postconditioning Used to Limit Final Infarct Size in Patients With Acute ST-segment Elevation Myocardial Infarction
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
POSTCON
Brief Summary:
Standard treatment of patients with acute ST-segment elevation myocardial infarction consist of acute re-opening of the occluded coronary artery primary PCI Despite successful treatment of the epicardial vessel reperfusion is sometimes inadequate leading to large final infarct sizes This phenomenon is known as the reperfusion injury Several animal studies have indicated that graded re-opening of the artery may limit tissue damage Generally this is referred to as mechanical postconditioning
The study investigates the effect on final infarct size evaluated by magnetic resonance scan of postconditioning of ST-segment elevation myocardial infarctions Mechanical postconditioning is performed by means of several balloon inflations in the injured vessel following its acute re-opening
The study investigates the effect on final infarct size evaluated by magnetic resonance scan of postconditioning of ST-segment elevation myocardial infarctions Mechanical postconditioning is performed by means of several balloon inflations in the injured vessel following its acute re-opening
Detailed Description:
Please see above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None